Literature DB >> 20937951

Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase.

Jing He1, Ana-Maria Iosif, Dong Young Lee, Oliver Martinez, Shuguang Chu, Owen Carmichael, James A Mortimer, Qianhua Zhao, Ding Ding, Qihao Guo, Douglas Galasko, David P Salmon, Qi Dai, Yougui Wu, Ronald C Petersen, Zhen Hong, Amy R Borenstein, Charles DeCarli.   

Abstract

OBJECTIVE: To investigate the associations among brain morphologic changes as seen on magnetic resonance imaging (MRI), cerebrovascular risk (CVR), and clinical diagnosis and cognition in elderly patients with mild cognitive impairment and dementia living in urban Shanghai.
DESIGN: Cross-sectional study performed from May 1, 2007, to November 31, 2008.
SETTING: Memory Disorders Clinic of the Huashan Hospital and the Shanghai community. PARTICIPANTS: Ninety-six older people: 32 with normal cognition (NC), 30 with amnestic mild cognitive impairment (aMCI), and 34 with dementia. MAIN OUTCOME MEASURES: For each patient, we administered a neurologic and physical examination, neuropsychological evaluation, and brain MRI and genotyped the apolipoprotein E-ε4 (APOE-ε4) gene. The volumes determined by MRI were assessed using a semiautomatic method.
RESULTS: Brain volume was significantly smaller in the dementia patients compared with the NC (P < .001) and aMCI patients (P = .04). Hippocampal volume (HV) was lower and white matter hyperintensity (WMH) volume was higher in those with aMCI (HV: P = .03; WMH volume: P = .04) and dementia (HV: P < .001; WMH volume: P = .002) compared with NC participants. The presence of APOE-ε4 was significantly associated with reduced HV (P = .02). Systolic blood pressure was positively associated with CVR score (P = .04); diastolic blood pressure (P = .02) and CVR score (P = .04) were positively associated with WMH volume. The WMH volume (P = .03) and CVR score (P = .03) were higher among dementia patients compared with NC participants.
CONCLUSIONS: Brain structure changes seen on MRI were significantly associated with clinical diagnosis. In addition, blood pressure was highly associated with CVR score and WMH volume. These results suggest that MRI is a valuable measure of brain injury in a Chinese cohort and can serve to assess the effects of various degenerative and cerebrovascular diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20937951      PMCID: PMC3051396          DOI: 10.1001/archneurol.2010.230

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  47 in total

1.  Comparison of Alzheimer's disease risk factors in white and African American families.

Authors:  D L Bachman; R C Green; K S Benke; L A Cupples; L A Farrer
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

2.  Hippocampal volume and retention in Alzheimer's disease.

Authors:  Joel H Kramer; Norbert Schuff; Bruce R Reed; Dan Mungas; An-Tao Du; Howard J Rosen; William J Jagust; Bruce L Miller; Michael W Weiner; Helena C Chui
Journal:  J Int Neuropsychol Soc       Date:  2004-07       Impact factor: 2.892

3.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

4.  Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.

Authors:  Denis A Evans; David A Bennett; Robert S Wilson; Julia L Bienias; Martha Clare Morris; Paul A Scherr; Liesi E Hebert; Neelum Aggarwal; Laurel A Beckett; Rajiv Joglekar; Elizabeth Berry-Kravis; Julie Schneider
Journal:  Arch Neurol       Date:  2003-02

Review 5.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

6.  Clinical validity of the Chinese version of Mattis Dementia Rating Scale in differentiating dementia of Alzheimer's type in Hong Kong.

Authors:  Agnes S Chan; Angel Choi; Helen Chiu; Linda Lam
Journal:  J Int Neuropsychol Soc       Date:  2003-01       Impact factor: 2.892

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Incidence and prevalence of dementia in the Cardiovascular Health Study.

Authors:  Annette L Fitzpatrick; Lewis H Kuller; Diane G Ives; Oscar L Lopez; William Jagust; John C S Breitner; Beverly Jones; Constantine Lyketsos; Corinne Dulberg
Journal:  J Am Geriatr Soc       Date:  2004-02       Impact factor: 5.562

9.  MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease.

Authors:  C R Jack; R C Petersen; P C O'Brien; E G Tangalos
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

Review 10.  The role of cerebrovascular disease in dementia.

Authors:  Charles DeCarli
Journal:  Neurologist       Date:  2003-05       Impact factor: 1.398

View more
  7 in total

1.  Cerebrovascular disease, β-amyloid, and cognition in aging.

Authors:  Natalie L Marchant; Bruce R Reed; Charles S DeCarli; Cindee M Madison; Michael W Weiner; Helena C Chui; William J Jagust
Journal:  Neurobiol Aging       Date:  2011-11-01       Impact factor: 4.673

2.  Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants.

Authors:  Naftali Raz; Yiqin Yang; Cheryl L Dahle; Susan Land
Journal:  Biochim Biophys Acta       Date:  2011-08-25

3.  Recruiting US Chinese Elders Into Clinical Research for Dementia.

Authors:  Clara Li; Judith Neugroschl; Mari Umpierre; Jane Martin; QiYing Huang; Xiaoyi Zeng; Dongming Cai; Mary Sano
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Oct-Dec       Impact factor: 2.703

Review 4.  APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.

Authors:  Sabrina Schilling; Anita L DeStefano; Perminder S Sachdev; Seung Hoan Choi; Karen A Mather; Charles D DeCarli; Wei Wen; Peter Høgh; Naftali Raz; Rhoda Au; Alexa Beiser; Philip A Wolf; José Rafael Romero; Yi-Cheng Zhu; Kathryn L Lunetta; Lindsay Farrer; Carole Dufouil; Lewis H Kuller; Bernard Mazoyer; Sudha Seshadri; Christophe Tzourio; Stéphanie Debette
Journal:  Neurology       Date:  2013-07-16       Impact factor: 9.910

5.  Alzheimer Disease-associated Cortical Atrophy Does not Differ Between Chinese and Whites.

Authors:  Jia Fan; Marian Tse; Jessie S Carr; Bruce L Miller; Joel H Kramer; Howard J Rosen; Luke W Bonham; Jennifer S Yokoyama
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Jul-Sep       Impact factor: 2.703

6.  Long-term cognitive function change among breast cancer survivors.

Authors:  Ying Zheng; Jianfeng Luo; Pingping Bao; Hui Cai; Zhen Hong; Ding Ding; James C Jackson; Xiao-Ou Shu; Qi Dai
Journal:  Breast Cancer Res Treat       Date:  2014-07-09       Impact factor: 4.872

7.  Apolipoprotein ε4 is associated with lower brain volume in cognitively normal Chinese but not white older adults.

Authors:  Jennifer S Yokoyama; Allen K L Lee; Leonel T Takada; Edgar Busovaca; Luke W Bonham; Steven Z Chao; Marian Tse; Jing He; Christopher G Schwarz; Owen T Carmichael; Brandy R Matthews; Anna Karydas; Michael W Weiner; Giovanni Coppola; Charles S DeCarli; Bruce L Miller; Howard J Rosen
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.